CD4 and inflammatory bowel disease: One can speculate that sema4A co-presence with Treg cells in the inflamed bowel could possibly be a regulatory block, decreasing by this CD4+ T cell activation, and therefore, becomes a frontier regulator in active IBD, while at the same time, also a marker for disease activity.